OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+24.27%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$115M
AUM Growth
+$115M
(-34%)
Cap. Flow
+$1.99M
Cap. Flow
% of AUM
1.73%
Top 10 Holdings %
Top 10 Hldgs %
93.24%
Holding
26
New
2
Increased
5
Reduced
7
Closed
4
Top Buys
| 1 |
Pacific Biosciences
PACB
|
$6.23M |
| 2 |
Moderna
MRNA
|
$5.55M |
| 3 |
Biohaven
BHVN
|
$2.98M |
| 4 |
ProShares UltraPro QQQ
TQQQ
|
$2.6M |
| 5 |
Ardelyx
ARDX
|
$2.19M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$10.7M |
| 2 |
Opko Health
OPK
|
$2.34M |
| 3 |
ImmunityBio
IBRX
|
$1.57M |
| 4 |
GeneDx Holdings
WGS
|
$1.56M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$574K |
Sector Composition
| 1 | Healthcare | 96.99% |
| 2 | Energy | 0% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
QuidelOrtho
QDEL
$1.95B
| $42.8M | 35.68% |
499,263
| – | – |
|
|
2
Pacific Biosciences
PACB
$393M
| $17.6M | 14.7% |
2,154,807
+761,642
| +55% | +$6.23M |
|
|
AGEN
3
Agenus
AGEN
$133M
| $11.7M | 9.79% |
4,890,872
+399,612
| +9% | +$959K |
|
|
4
Biohaven
BHVN
$1.63B
| $8.42M | 7.03% |
606,776
+214,576
| +55% | +$2.98M |
|
|
5
BioCryst Pharmaceuticals
BCRX
$1.74B
| $6.72M | 5.6% |
585,194
-50,000
| -8% | -$574K |
|
|
6
Moderna
MRNA
$9.37B
| $5.55M | 4.63% |
+30,900
| New | +$5.55M |
|
|
7
Opko Health
OPK
$1.1B
| $4.04M | 3.37% |
3,230,288
-1,872,468
| -37% | -$2.34M |
|
8
Forian
FORA
$61.3M
| $3.69M | 3.08% |
1,351,257
-57,175
| -4% | -$156K |
|
|
9
ProShares UltraPro QQQ
TQQQ
$26B
| $3.46M | 2.89% |
200,000
+150,000
| +300% | +$2.6M |
|
|
MRTX
10
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.19M | 2.66% |
70,453
-235,176
| -77% | -$10.7M |
|
|
IMMP
11
Immutep
IMMP
$234M
| $2.52M | 2.11% |
1,442,325
-115,000
| -7% | -$201K |
|
|
12
Ardelyx
ARDX
$1.53B
| $2.19M | 1.83% |
+769,230
| New | +$2.19M |
|
|
AXDX
13
DELISTED
Accelerate Diagnostics
AXDX
| $1.15M | 0.96% |
1,628,077
-580,795
| -26% | -$410K |
|
14
Biogen
BIIB
$19.4B
| $668K | 0.56% |
2,412
| – | – |
|
|
15
GeneDx Holdings
WGS
$3.72B
| $657K | 0.55% |
2,490,010
-5,913,916
| -70% | -$1.56M |
|
|
DMTK
16
DELISTED
DermTech, Inc. Common Stock
DMTK
| $338K | 0.28% |
190,769
+14,200
| +8% | +$25.1K |
|
|
AWH
17
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $242K | 0.2% |
728,100
| – | – |
|
|
18
ImmunityBio
IBRX
$2.21B
| – | – |
-315,322
| Closed | -$1.57M |
|
19
iShares Russell 2000 ETF
IWM
$67B
| – | – |
0
| – | – |
|
20
Pfizer
PFE
$141B
| – | – |
0
| – | – |
|
21
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
22
Tenet Healthcare
THC
$16.3B
| – | – |
0
| – | – |
|
23
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
-6,633
| Closed | -$526K |
|
|
VTNR
24
DELISTED
Vertex Energy, Inc
VTNR
| – | – |
0
| – | – |
|
|
VLD
25
DELISTED
Velo3D, Inc.
VLD
| – | – |
-65,000
| Closed | -$256K |
|